439 related articles for article (PubMed ID: 11481352)
1. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
Ris MD; Packer R; Goldwein J; Jones-Wallace D; Boyett JM
J Clin Oncol; 2001 Aug; 19(15):3470-6. PubMed ID: 11481352
[TBL] [Abstract][Full Text] [Related]
2. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
Kao GD; Goldwein JW; Schultz DJ; Radcliffe J; Sutton L; Lange B
Cancer; 1994 Aug; 74(3):965-71. PubMed ID: 8039126
[TBL] [Abstract][Full Text] [Related]
3. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
4. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
[TBL] [Abstract][Full Text] [Related]
5. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
6. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study.
Prados MD; Edwards MS; Chang SM; Russo C; Davis R; Rabbitt J; Page M; Lamborn K; Wara WM
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):279-85. PubMed ID: 10030250
[TBL] [Abstract][Full Text] [Related]
7. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
[TBL] [Abstract][Full Text] [Related]
8. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Scantlebury N; Law N; Spiegler BJ; Malkin D; Janzen L; Mabbott D
J Clin Oncol; 2014 Jun; 32(17):1760-8. PubMed ID: 24516024
[TBL] [Abstract][Full Text] [Related]
9. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
Allen JC; Donahue B; DaRosso R; Nirenberg A
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
[TBL] [Abstract][Full Text] [Related]
11. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.
Câmara-Costa H; Resch A; Kieffer V; Lalande C; Poggi G; Kennedy C; Bull K; Calaminus G; Grill J; Doz F; Rutkowski S; Massimino M; Kortmann RD; Lannering B; Dellatolas G; Chevignard M;
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):978-985. PubMed ID: 26194675
[TBL] [Abstract][Full Text] [Related]
13. Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score.
Silber JH; Radcliffe J; Peckham V; Perilongo G; Kishnani P; Fridman M; Goldwein JW; Meadows AT
J Clin Oncol; 1992 Sep; 10(9):1390-6. PubMed ID: 1517781
[TBL] [Abstract][Full Text] [Related]
14. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
15. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.
Duffner PK; Horowitz ME; Krischer JP; Burger PC; Cohen ME; Sanford RA; Friedman HS; Kun LE
Neuro Oncol; 1999 Apr; 1(2):152-61. PubMed ID: 11554387
[No Abstract] [Full Text] [Related]
16. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors.
Kieffer-Renaux V; Viguier D; Raquin MA; Laurent-Vannier A; Habrand JL; Dellatolas G; Kalifa C; Hartmann O; Grill J
Pediatr Blood Cancer; 2005 Nov; 45(6):814-9. PubMed ID: 15924360
[TBL] [Abstract][Full Text] [Related]
17. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Sawamura Y; Ikeda J; Ishii N; Kato T; Tada M; Abe H; Shirato H
Neurol Med Chir (Tokyo); 1996 Sep; 36(9):632-8. PubMed ID: 8913079
[TBL] [Abstract][Full Text] [Related]
18. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
Carrie C; Grill J; Figarella-Branger D; Bernier V; Padovani L; Habrand JL; Benhassel M; Mege M; Mahé M; Quetin P; Maire JP; Baron MH; Clavere P; Chapet S; Maingon P; Alapetite C; Claude L; Laprie A; Dussart S
J Clin Oncol; 2009 Apr; 27(11):1879-83. PubMed ID: 19273707
[TBL] [Abstract][Full Text] [Related]
19. Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma.
Palmer SL; Gajjar A; Reddick WE; Glass JO; Kun LE; Wu S; Xiong X; Mulhern RK
Neuropsychology; 2003 Oct; 17(4):548-55. PubMed ID: 14599268
[TBL] [Abstract][Full Text] [Related]
20. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]